Cephalotaxus harringtonia has garnered recent attention for its promising medicinal properties attributed to its alkaloid composition, including harringtonine and homoharringtonine known for their radical scavenging activities. High-performance liquid chromatography was used to assess the distribution of harringtonine, homoharringtonine, and ginkgetin in different plant parts of C. harringtonia. Additionally, DPPH and ABTS+ assays were conducted to evaluate the radical scavenging activity of C. harringtonia extracts. These results revealed that bud extracts from C. harringtonia exhibited the highest levels of polyphenols, along with elevated concentrations of harringtonine and homoharringtonine; nevertheless, this phenomenon only marginally influenced their antioxidant potential. These results suggest that, although a high concentration of compounds was detected in the buds of C. harringtonia, the detected compounds and their correlationwith radical scavenging activity appears to be weak. While harringtonine and homoharringtonine are synthesized and maintained at elevated levels within buds to fulfill various physiological functions, including modulation of signal transduction pathways and reinforcement of defense mechanisms, the involvement of other constituents and the potential synergistic interactions among compounds cannot be overlooked in mediating the observed radical scavenging activity. Moreover, the significant concentrations of harringtonine and homoharringtonine in bud extracts highlight the potential applications of C. harringtonia in the pharmaceutical industry and other similar fields. This study emphasizes the imperativeness of further exploring the medicinal applications of C. harringtonia and underscores its prospective implications in pharmaceutical and functional materials development.